跳至主要内容
临床试验/NCT01430663
NCT01430663已完成不适用

Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples

Heidelberg University9 个研究点 分布在 2 个国家目标入组 87 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
87
试验地点
9
主要终点
Clinical significance of biomarker based diagnostic investigation in suspected invasive aspergillosis

研究概览

简要总结

Diagnosing invasive pulmonary aspergillosis (IPA) remains a challenge in patients (pts) with hematological malignancies. The clinical significance of testing bronchoalveolar lavage (BAL) samples both with polymerase chain reaction (PCR) and Aspergillus galactomannan (GM) ELISA is unclear, and the BAL cutoff for GM has not been clearly defined yet. Using a validated nested PCR assay and a GM ELISA, we prospectively examine BAL samples from hematological patients at high risk of PA.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
5 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hematological patients with lung infiltrates at high risk for invasive aspergillosis

排除标准

  • patients without informed consent

结局指标

主要结局

Clinical significance of biomarker based diagnostic investigation in suspected invasive aspergillosis

时间窗: up to 18 months

次要结局

  • Evaluation of diagnostic and therapeutic intervention concerning antifungal treatment with regard to outcome (overall survival, in months) of a fungal infection(up to 18 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dieter Buchheidt

Prof. Dr. med.

Heidelberg University

研究点 (9)

Loading locations...

相似试验